Microfluidics

Microfluidics

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $15M

Overview

Microfluidics is a long-established, privately-held leader in high-pressure homogenization technology. Its core Microfluidizer® processors are engineered to deliver unparalleled shear forces, enabling uniform particle size reduction, efficient cell lysis, and consistent nanoemulsion production with seamless scalability from lab to production. The company serves a global customer base in R&D and manufacturing, with a strong reputation for technical support, process repeatability, and superior yields compared to alternative methods like sonication or traditional homogenizers.

Drug Delivery

Technology Platform

Proprietary high-pressure, high-shear fluid processing technology (Microfluidizer®) for uniform particle size reduction, cell disruption, and nanoemulsion formation. Features fixed-geometry interaction chambers for consistent, scalable results.

Funding History

2
Total raised:$15M
Series A$12M
Seed$3M

Opportunities

Growth is driven by the expansion of nanotechnology, particularly in lipid nanoparticle (LNP) production for mRNA/gene therapies and nano-formulations for poorly soluble drugs.
Additional opportunities exist in cosmetics, food science, and advanced material synthesis where uniform nanoemulsions and particle size control are critical.

Risk Factors

Key risks include dependence on cyclical capital expenditure in pharma and academia, competition from alternative homogenization technologies, and potential supply chain disruptions for precision-engineered components.
Technological obsolescence is a constant threat requiring ongoing R&D.

Competitive Landscape

Competes with other high-pressure homogenizer manufacturers like Avestin (part of BEE International), GEA Niro Soavi, and SPX FLOW. Microfluidics differentiates by claiming superior shear rates, more uniform particle size distributions, seamless scalability, and lower maintenance, as supported by user testimonials comparing it to sonication and French press methods.